{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:26:45Z","timestamp":1781753205577,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["#2019\u221223822"],"award-info":[{"award-number":["#2019\u221223822"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s13304-023-01735-w","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T20:01:47Z","timestamp":1704484907000},"page":"345-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Locally advanced mid\/low rectal cancer with synchronous resectable liver metastases: systematic review of the available strategies and outcome"],"prefix":"10.1007","volume":"76","author":[{"given":"R.","family":"Tutino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Zingaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Ragaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4108-4832","authenticated-orcid":false,"given":"L.","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"10","key":"1735_CR1","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14(10):101174. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174","journal-title":"Transl Oncol"},{"key":"1735_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M et al (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683\u2013691. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912","journal-title":"Gut"},{"issue":"9","key":"1735_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","volume":"41","author":"R Adam","year":"2015","unstructured":"Adam R, de Gramont A, Figueras J et al (2015) Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41(9):729\u2013741. https:\/\/doi.org\/10.1016\/j.ctrv.2015.06.006","journal-title":"Cancer Treat Rev"},{"key":"1735_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3925-x","author":"J Engstrand","year":"2018","unstructured":"Engstrand J, Nilsson H, Str\u00f6mberg C et al (2018) Colorectal cancer liver metastases\u2014a population-based study on incidence, management and survival. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-017-3925-x","journal-title":"BMC Cancer"},{"key":"1735_CR5","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","volume":"27","author":"S Kopetz","year":"2009","unstructured":"Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677\u20133683. https:\/\/doi.org\/10.1200\/JCO.2008.20.5278","journal-title":"J Clin Oncol"},{"key":"1735_CR6","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.surg.2018.01.004","volume":"163","author":"JM Creasy","year":"2018","unstructured":"Creasy JM, Sadot E, Koerkamp BG et al (2018) Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? Surgery (United States) 163:1238\u20131244. https:\/\/doi.org\/10.1016\/j.surg.2018.01.004","journal-title":"Surgery (United States)"},{"key":"1735_CR7","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1245\/s10434-008-9935-9","volume":"15","author":"L Vigan\u00f2","year":"2008","unstructured":"Vigan\u00f2 L, Ferrero A, Lo Tesoriere R, Capussotti L (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458\u20132464. https:\/\/doi.org\/10.1245\/s10434-008-9935-9","journal-title":"Ann Surg Oncol"},{"key":"1735_CR8","doi-asserted-by":"publisher","first-page":"103853","DOI":"10.1016\/j.critrevonc.2022.103853","volume":"180","author":"F Petrelli","year":"2022","unstructured":"Petrelli F, Trevisan F, Tomasello G et al (2022) Different neoadjuvant therapies for locally advanced rectal cancer: a systematic review and network meta-analysis. Crit Rev Oncol Hematol 180:103853. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103853","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9617","key":"1735_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007\u20131016","journal-title":"Lancet"},{"issue":"6","key":"1735_CR10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.ejso.2016.08.019","volume":"43","author":"M Okuno","year":"2017","unstructured":"Okuno M, Hatano E, Nishino H et al (2017) Does response rate of chemotherapy with molecular target agents correlate with the conversion rate and survival in patients with unresectable colorectal liver metastases?: a systematic review. Eur J Surg Oncol 43(6):1003\u20131012. https:\/\/doi.org\/10.1016\/j.ejso.2016.08.019","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"1735_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/bjs\/znac010","volume":"109","author":"L Vigano","year":"2022","unstructured":"Vigano L, Terrone A, Costa G et al (2022) Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases. Br J Surg 109(5):401\u2013404. https:\/\/doi.org\/10.1093\/bjs\/znac010","journal-title":"Br J Surg"},{"issue":"6","key":"1735_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3748\/wjg.v28.i6.608","volume":"28","author":"L Vigan\u00f2","year":"2022","unstructured":"Vigan\u00f2 L, Jayakody Arachchige VS, Fiz F et al (2022) Is precision medicine for colorectal liver metastases still a utopia? New perspectives by modern biomarkers, radiomics, and artificial intelligence. World J Gastroenterol 28(6):608\u2013623. https:\/\/doi.org\/10.3748\/wjg.v28.i6.608","journal-title":"World J Gastroenterol"},{"key":"1735_CR13","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s13304-021-01100-9","volume":"73","author":"A Rocca","year":"2021","unstructured":"Rocca A, Cipriani F, Belli G et al (2021) The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: a Delphi methodology. Updates Surg 73:1247\u20131265. https:\/\/doi.org\/10.1007\/s13304-021-01100-9","journal-title":"Updates Surg"},{"issue":"7","key":"1735_CR14","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/bjs.5346","volume":"93","author":"G Mentha","year":"2006","unstructured":"Mentha G, Majno PE, Andres A et al (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93(7):872\u2013878. https:\/\/doi.org\/10.1002\/bjs.5346","journal-title":"Br J Surg"},{"key":"1735_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.hpb.2017.11.004","volume":"20","author":"VT Valdimarsson","year":"2018","unstructured":"Valdimarsson VT, Syk I, Lindell G et al (2018) Outcomes of liver-first strategy and classical strategy for synchronous colorectal liver metastases in Sweden. HPB 20:441\u2013447. https:\/\/doi.org\/10.1016\/j.hpb.2017.11.004","journal-title":"HPB"},{"key":"1735_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/codi.14019","volume":"20","author":"AE Vallance","year":"2018","unstructured":"Vallance AE, van der Meulen J, Kuryba A et al (2018) The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. Colorectal Dis 20:486\u2013495. https:\/\/doi.org\/10.1111\/codi.14019","journal-title":"Colorectal Dis"},{"issue":"2","key":"1735_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13304-021-01234-w","volume":"74","author":"F Carbone","year":"2022","unstructured":"Carbone F, Chee Y, Rasheed S et al (2022) Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach. Updates Surg 74(2):451\u2013465. https:\/\/doi.org\/10.1007\/s13304-021-01234-w","journal-title":"Updates Surg"},{"key":"1735_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","volume":"18","author":"J Erlandsson","year":"2017","unstructured":"Erlandsson J, Holm T, Pettersson D et al (2017) Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 18:336\u2013346. https:\/\/doi.org\/10.1016\/S1470-2045(17)30086-4","journal-title":"Lancet Oncol"},{"key":"1735_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12029-018-0141-0","volume":"49","author":"RAF Agas","year":"2018","unstructured":"Agas RAF, Co LBA, Jacinto JCKM et al (2018) Neoadjuvant radiotherapy versus no radiotherapy for stage IV rectal cancer: a systematic review and meta-analysis. J Gastrointest Cancer 49:389\u2013401. https:\/\/doi.org\/10.1007\/s12029-018-0141-0","journal-title":"J Gastrointest Cancer"},{"key":"1735_CR20","doi-asserted-by":"publisher","first-page":"101930","DOI":"10.1016\/j.ctrv.2019.101930","volume":"82","author":"G Bregni","year":"2020","unstructured":"Bregni G, Akin Telli T, Camera S et al (2020) Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines. Cancer Treat Rev 82:101930. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101930","journal-title":"Cancer Treat Rev"},{"key":"1735_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"The BMJ"},{"key":"1735_CR22","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1007\/s00268-011-1272-7","volume":"35","author":"L Vigan\u00f2","year":"2011","unstructured":"Vigan\u00f2 L, Karoui M, Ferrero A et al (2011) Locally advanced mid\/low rectal cancer with synchronous liver metastases. World J Surg 35:2788\u20132795. https:\/\/doi.org\/10.1007\/s00268-011-1272-7","journal-title":"World J Surg"},{"key":"1735_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1748-717X-5-75","volume":"5","author":"JW Kim","year":"2010","unstructured":"Kim JW, Kim YB, Kim NK et al (2010) The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study. Radiation Oncol 5:75","journal-title":"Radiation Oncol"},{"key":"1735_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-99","author":"SJ Shin","year":"2011","unstructured":"Shin SJ, Yoon HI, Kim NK et al (2011) Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiation Oncol. https:\/\/doi.org\/10.1186\/1748-717X-6-99","journal-title":"Radiation Oncol"},{"key":"1735_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijrobp.2011.10.070","volume":"84","author":"HJ An","year":"2012","unstructured":"An HJ, Yu CS, Yun SC et al (2012) Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence. Int J Radiat Oncol Biol Phys 84:73\u201380. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.070","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1735_CR26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.surg.2013.02.010","volume":"154","author":"G Manceau","year":"2013","unstructured":"Manceau G, Brouquet A, Bachet JB et al (2013) Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases. Surgery (United States) 154:528\u2013535. https:\/\/doi.org\/10.1016\/j.surg.2013.02.010","journal-title":"Surgery (United States)"},{"key":"1735_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0839-1","author":"M Jung","year":"2014","unstructured":"Jung M, Holmqvist A, Sun XF, Albertsson M (2014) A clinical study of metastasized rectal cancer treatment: assessing a multimodal approach. Med Oncol. https:\/\/doi.org\/10.1007\/s12032-014-0839-1","journal-title":"Med Oncol"},{"key":"1735_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijsu.2015.08.034","volume":"23","author":"C Sabbagh","year":"2015","unstructured":"Sabbagh C, Cosse C, Ravololoniaina T et al (2015) Oncological strategies for middle and low rectal cancer with synchronous liver metastases. Int J Surg 23:186\u2013193. https:\/\/doi.org\/10.1016\/j.ijsu.2015.08.034","journal-title":"Int J Surg"},{"key":"1735_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/COC.0000000000000315","volume":"39","author":"H Cho","year":"2016","unstructured":"Cho H, Kim JE, Kim KP et al (2016) Phase II study of preoperative capecitabine and oxaliplatin-based intensified chemoradiotherapy with or without induction chemotherapy in patients with locally advanced rectal cancer and synchronous liver-limited resectable metastases. Am JClin Oncol 39:623\u2013629. https:\/\/doi.org\/10.1097\/COC.0000000000000315","journal-title":"Am JClin Oncol"},{"key":"1735_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/codi.13622","volume":"19","author":"KJ Labori","year":"2017","unstructured":"Labori KJ, Guren MG, Brudvik KW et al (2017) Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal Dis 19:731\u2013738. https:\/\/doi.org\/10.1111\/codi.13622","journal-title":"Colorectal Dis"},{"key":"1735_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-017-1123-6","author":"M D\u2019Hondt","year":"2017","unstructured":"D\u2019Hondt M, Lucidi V, Vermeiren K et al (2017) The interval approach: an adaptation of the liver-first approach to treat synchronous liver metastases from rectal cancer. World J Surg Oncol. https:\/\/doi.org\/10.1186\/s12957-017-1123-6","journal-title":"World J Surg Oncol"},{"key":"1735_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/jgo.2017.06.07","volume":"8","author":"CC Fossum","year":"2017","unstructured":"Fossum CC, Alabbad JY, Romak LB et al (2017) The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis. J Gastrointest Oncol 8:650\u2013658","journal-title":"J Gastrointest Oncol"},{"key":"1735_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/0284186X.2017.1296584","volume":"56","author":"T Bird","year":"2017","unstructured":"Bird T, Michael M, Bressel M et al (2017) FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases. Acta Oncol (Madr) 56:646\u2013652. https:\/\/doi.org\/10.1080\/0284186X.2017.1296584","journal-title":"Acta Oncol (Madr)"},{"key":"1735_CR34","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s12094-017-1818-8","volume":"20","author":"H Salvador-Ros\u00e9s","year":"2018","unstructured":"Salvador-Ros\u00e9s H, L\u00f3pez-Ben S, Casellas-Robert M et al (2018) Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: a comparison of short-term outcomes. Clin Transl Oncol 20:1018\u20131025. https:\/\/doi.org\/10.1007\/s12094-017-1818-8","journal-title":"Clin Transl Oncol"},{"key":"1735_CR35","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/codi.15064","volume":"22","author":"ME Kelly","year":"2020","unstructured":"Kelly ME, Aalbers AGJ, Abdul Aziz N et al (2020) Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. Colorectal Dis 22:1258\u20131262. https:\/\/doi.org\/10.1111\/codi.15064","journal-title":"Colorectal Dis"},{"key":"1735_CR36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ejso.2020.09.015","volume":"47","author":"S Conci","year":"2021","unstructured":"Conci S, Ruzzenente A, Pedrazzani C et al (2021) Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes. Eur J Surg Oncol 47:842\u2013849. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.015","journal-title":"Eur J Surg Oncol"},{"key":"1735_CR37","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1016\/j.ejso.2021.05.018","volume":"47","author":"HW Bae","year":"2021","unstructured":"Bae HW, Kim HS, Yang SY et al (2021) Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases. Eur J Surg Oncol 47:2814\u20132820. https:\/\/doi.org\/10.1016\/j.ejso.2021.05.018","journal-title":"Eur J Surg Oncol"},{"key":"1735_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/codi.15912","volume":"24","author":"N Russolillo","year":"2022","unstructured":"Russolillo N, Gentile V, Ratti F et al (2022) Incidence and predictors of textbook outcome after simultaneous liver and rectal surgeries for Stage IV rectal cancer. Colorectal Dis 24:50\u201358. https:\/\/doi.org\/10.1111\/codi.15912","journal-title":"Colorectal Dis"},{"key":"1735_CR39","doi-asserted-by":"publisher","DOI":"10.1245\/s10434","author":"F Giuliante","year":"2021","unstructured":"Giuliante F, Vigan\u00f2 L, De Rose AM et al (2021) Liver-first approach for synchronous colorectal metastases: analysis of 7360 patients from the livermetsurvey registry. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434","journal-title":"Ann Surg Oncol"},{"key":"1735_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21037\/tcr-21-1399","volume":"11","author":"J Chen","year":"2022","unstructured":"Chen J, Chen H, Zhao F et al (2022) Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study. Transl Cancer Res 11:171\u2013180. https:\/\/doi.org\/10.21037\/tcr-21-1399","journal-title":"Transl Cancer Res"},{"key":"1735_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/bjs\/znad013","volume":"110","author":"JM Van Rees","year":"2023","unstructured":"Van Rees JM, Krul MF, Kok NFM et al (2023) Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies. Br J Surg 110:1049\u20131052. https:\/\/doi.org\/10.1093\/bjs\/znad013","journal-title":"Br J Surg"},{"key":"1735_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.05.023","author":"G Colletti","year":"2023","unstructured":"Colletti G, Ciniselli CM, Sorrentino L et al (2023) Multimodal treatment of rectal cancer with resectable synchronous liver metastases: a systematic review. Dig Liver Dis. https:\/\/doi.org\/10.1016\/j.dld.2023.05.023","journal-title":"Dig Liver Dis"},{"issue":"2","key":"1735_CR43","doi-asserted-by":"publisher","first-page":"E196","DOI":"10.1503\/cjs.005822","volume":"66","author":"GGRJ Johnson","year":"2023","unstructured":"Johnson GGRJ, Park J, Helewa RM et al (2023) Total neoadjuvant therapy for rectal cancer: a guide for surgeons. Can J Surg 66(2):E196\u2013E220. https:\/\/doi.org\/10.1503\/cjs.005822","journal-title":"Can J Surg"},{"key":"1735_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jso.23457","volume":"109","author":"HL Yeo","year":"2014","unstructured":"Yeo HL, Paty PB (2014) Management of recurrent rectal cancer: Practical insights in planning and surgical intervention. J Surg Oncol 109:47\u201352. https:\/\/doi.org\/10.1002\/jso.23457","journal-title":"J Surg Oncol"},{"key":"1735_CR45","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00423-021-02285-8","volume":"406","author":"M Kazi","year":"2021","unstructured":"Kazi M, Sukumar V, Desouza A, Saklani A (2021) State-of-the-art surgery for recurrent and locally advanced rectal cancers. Langenbecks Arch Surg 406:1763\u20131774. https:\/\/doi.org\/10.1007\/s00423-021-02285-8","journal-title":"Langenbecks Arch Surg"},{"key":"1735_CR46","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/SLA.0b013e3182734423","volume":"256","author":"A Andres","year":"2012","unstructured":"Andres A, Toso C, Adam R et al (2012) A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases. Ann Surg 256:772\u2013779. https:\/\/doi.org\/10.1097\/SLA.0b013e3182734423","journal-title":"Ann Surg"},{"issue":"1","key":"1735_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.hpb.2016.10.005","volume":"19","author":"C Sturesson","year":"2017","unstructured":"Sturesson C, Valdimarsson VT, Blomstrand E et al (2017) Liver-first strategy for synchronous colorectal liver metastases\u2014an intention-to-treat analysis. HPB (Oxford) 19(1):52\u201358. https:\/\/doi.org\/10.1016\/j.hpb.2016.10.005","journal-title":"HPB (Oxford)"},{"key":"1735_CR48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/bjs.10099","volume":"103","author":"FKS Welsh","year":"2016","unstructured":"Welsh FKS, Chandrakumaran K, John TG et al (2016) Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases. Br J Surg 103:600\u2013606. https:\/\/doi.org\/10.1002\/bjs.10099","journal-title":"Br J Surg"},{"key":"1735_CR49","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/bjs.10501","volume":"104","author":"AE Vallance","year":"2017","unstructured":"Vallance AE, vanderMeulen J, Kuryba A et al (2017) Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases. Br J Surg 104:918\u2013925. https:\/\/doi.org\/10.1002\/bjs.10501","journal-title":"Br J Surg"},{"key":"1735_CR50","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1245\/s10434-012-2628-4","volume":"20","author":"L Vigan\u00f2","year":"2013","unstructured":"Vigan\u00f2 L, Langella S, Ferrero A et al (2013) Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol 20:938\u2013945. https:\/\/doi.org\/10.1245\/s10434-012-2628-4","journal-title":"Ann Surg Oncol"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-023-01735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-023-01735-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-023-01735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T22:07:35Z","timestamp":1712268455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-023-01735-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1007\/s13304-023-01735-w","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Vigan\u00f2 L: received speaker\u2019s honoraria from Johnson & Johnson. The remaining authors: reported no biomedical financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study complies with the guidelines for human studies. The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. No Institutional Review Board approval was required (Review article).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}